InsiderTrades

Form 4 for AMD Advanced Micro Devices

Accepted 2025-09-12 00:00:00 ET · period of report 2025-09-10 · accession 0000002488-25-000151 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-09-12 2025-09-10 AMD Norrod Forrest Eugene EVP, GM DESG S - Sale+OE $160.93 -17.2K 313.8K -5% -$2.77M
D 2025-09-12 2025-09-10 AMD Norrod Forrest Eugene EVP, GM DESG M - OptEx $34.19 +8,200 331.0K +3% +$280.4K
D 2025-09-12 2025-09-10 AMD Norrod Forrest Eugene EVP, GM DESG M - OptEx $0.00 -8,200 24.6K -25% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-09-10 S D 400 $162.68 314,971 D — — (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025. (F6) Transaction executed in multiple trades at prices ranging from $162.58 to $162.76 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
2 Common Common Stock 2025-09-10 S D 3,834 $161.85 315,371 D — — (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025. (F5) Transaction executed in multiple trades at prices ranging from $161.52 to $162.50 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
3 Common Common Stock 2025-09-10 S D 3,652 $160.85 319,205 D — — (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025. (F4) Transaction executed in multiple trades at prices ranging from $160.51 to $161.50 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
4 Common Common Stock 2025-09-10 S D 8,191 $160.04 322,857 D — — (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025. (F3) Transaction executed in multiple trades at prices ranging from $159.51 to $160.48 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
5 Common Common Stock 2025-09-10 M A 8,200 $34.19 331,048 D — — (F1) The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 6, 2025.
6 Common Common Stock 2025-09-10 S D 1,123 $163.94 313,848 D — — (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025. (F7) Transaction executed in multiple trades at prices ranging from $163.79 to $164.38 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
7 Derivative Stock Option Grant 2025-09-10 M D 8,200 $0.00 24,637 D $34.19 · — to 2026-08-09 8,200 Common Stock (F8) The options vest 1/3 on each of August 9, 2020, 2021 and 2022.